Report updated May 11, 2026

Overview · Full Intel report in progress

Play Store →

2nd.MD is an established medical app that is completely free. With a 4.9/5 rating from 4K reviews, it shows polarized user reception.

What is 2nd.MD?

2nd.MD is a medical concierge service that connects users with board-certified specialists for expert consultations regarding serious diagnoses, surgeries, or chronic conditions. The platform facilitates the retrieval and consolidation of medical records to ensure specialists are prepared for video consultations, which can be scheduled within 3 to 5 days.

Current Momentum

v4.7

No release notes available.

AI-powered deep analysis surfacing high-signal insights. Still in beta, accuracy improves daily. For informational purposes only.

Competition

Rivals identification in progress

7-Day Rank Pulse 🇺🇸

Medical

No ranking data

Rating Pulse 🇺🇸

What makes this app unique?

How Is The App's Momentum Right Now?

Loading...

What Are The Key Features?

Care Team CoordinationStandard

Dedicated nurses assist users by recommending specialists and managing the retrieval and consolidation of medical records.

Video ConsultationsStandard

The platform enables direct video appointments with top specialists, now supporting the addition of a third participant.

Multi-Channel AccessStandard

Users can initiate care journeys and communicate with the Care Team via the app, email, website, or phone.

Account ActivationStandard

The app supports streamlined onboarding through a specific account activation code system.

How much does it cost?

Free

Who Built It?

Accolade, Inc. app icon 1
Accolade, Inc. app icon 2
Accolade, Inc. app icon 3
Accolade, Inc. app icon 4

Accolade

(183.5K)

Providing virtual primary care and mental health services to patients across the U.S. through on-demand digital consultations.

Portfolio

4

Apps

Free 3
Medical67%
Health & Fitness33%

Who is Accolade?

Accolade, Inc. operates a hybrid healthcare model that integrates virtual clinical care with benefits navigation to serve both individual consumers and employer-sponsored health plans. Their strategic moat is built on institutional-grade clinical vetting, sourcing physicians from top-tier U.S. medical institutions to differentiate their virtual offerings from standard telehealth providers. By consolidating urgent care, mental health, and complex case management into a single interface, they are positioning themselves as a centralized digital front door for enterprise healthcare benefits.

Who is Accolade for?

  • Employees
  • Health plan members seeking convenient
  • Remote access to primary care
  • Mental health support
Intense

Portfolio momentum

Released 11 updates across 4 apps in the last 6 months, with all top titles receiving updates within the last 30 days.

Last release · 2d agoActive apps · 4

Analysis in progress, available soon

What do users think recently?

Analysis in progress, available soon

Analysis in progress, available soon

What is the competitive landscape for 2nd.MD?

How's The Medical Market?

Market outlook for this category

Available very soon

Strategic analysis coming soon

SWOT, key takeaways & outlook

The outtake for 2nd.MD

Key Takeaways

2nd.MD functions as a specialized concierge service designed to expedite access to expert medical second opinions for complex health concerns.

Where Is It Heading?

Trend analysis

Available very soon

Disclosure

Independent intel to help builders create better apps.

AI-powered analysis with editorial review, built from publicly available sources. See methodology.

Marlvel.ai is not affiliated with, endorsed by, or sponsored by 2nd.MD, its developer, the app publisher, Apple, or Google Play. All trademarks, logos, and screenshots referenced remain the property of their respective owners.

Hope this helps & keep building! · Found an error?

What's new in this report

No changes detected yet.

Cite this report

Marlvel.ai. “2nd.MD Intelligence Report.” Updated May 11, 2026. https://marlvel.ai/intel-report/medical/2nd-md

Agent Markdown (.md)·

Data licensed under CC-BY-NC 4.0